Company profile TRVI
There is not enough data for Trevi Therapeutics - Company Profile to provide analysis
There is not enough data for Trevi Therapeutics - Company Profile to provide correlation calculation
There is not enough data for Trevi Therapeutics - Company Profile to provide analysis
There is not enough data for Trevi Therapeutics ticker to provide analysis
There is not enough data for Trevi Therapeutics ticker to provide correlation calculation
There is not enough data for Trevi Therapeutics ticker to provide analysis
There is not enough data for Trevi Therapeutics news to provide analysis
There is not enough data for Trevi Therapeutics news to provide correlation calculation
There is not enough data for Trevi Therapeutics news to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Trevi Therapeutics stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 166 inf% QoQ | 280 68.7% QoQ | 52 -81.4% QoQ |
| 2020 | 156 inf% YoY 200.0% QoQ | 76 -54.2% YoY -51.3% QoQ | 89 -68.2% YoY 17.1% QoQ | 96 84.6% YoY 7.9% QoQ |
| 2021 | 123 -21.2% YoY 28.1% QoQ | 139 82.9% YoY 13.0% QoQ | 39 -56.2% YoY -71.9% QoQ | 167 74.0% YoY 328.2% QoQ |
| 2022 | 72 -41.5% YoY -56.9% QoQ | 218 56.8% YoY 202.8% QoQ | 114 192.3% YoY -47.7% QoQ | 166 -0.6% YoY 45.6% QoQ |
| 2023 | 120 66.7% YoY -27.7% QoQ | 39 -82.1% YoY -67.5% QoQ | 38 -66.7% YoY -2.6% QoQ | 213 28.3% YoY 460.5% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Trevi Therapeutics stock was 9.05 per week. The last year interest of Trevi Therapeutics stock compared to the last 5 years has changed by -28.62%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -45.62%.
There is not enough data for Trevi Therapeutics headquarters to provide analysis
There is not enough data for Trevi Therapeutics headquarters to provide correlation calculation
There is not enough data for Trevi Therapeutics headquarters to provide analysis
There is not enough data for Haduvio drug to provide analysis
There is not enough data for Haduvio drug to provide correlation calculation
There is not enough data for Haduvio drug to provide analysis
There is not enough data for Haduvio clinical trial to provide analysis
There is not enough data for Haduvio clinical trial to provide correlation calculation
There is not enough data for Haduvio clinical trial to provide analysis
There is not enough data for chronic pruritus treatment to provide analysis
There is not enough data for chronic pruritus treatment to provide correlation calculation
There is not enough data for chronic pruritus treatment to provide analysis
After 39 days of this quarter the interest is at 218.0. Based on that we can calculate that during remaining 52 days it will total up to 509.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 337 | 394 16.9% QoQ | 248 -37.1% QoQ | 371 49.6% QoQ |
| 2020 | 415 23.1% YoY 11.9% QoQ | 261 -33.8% YoY -37.1% QoQ | 372 50.0% YoY 42.5% QoQ | 343 -7.5% YoY -7.8% QoQ |
| 2021 | 264 -36.4% YoY -23.0% QoQ | 242 -7.3% YoY -8.3% QoQ | 427 14.8% YoY 76.4% QoQ | 444 29.4% YoY 4.0% QoQ |
| 2022 | 410 55.3% YoY -7.7% QoQ | 499 106.2% YoY 21.7% QoQ | 419 -1.9% YoY -16.0% QoQ | 554 24.8% YoY 32.2% QoQ |
| 2023 | 509 24.1% YoY -8.1% QoQ | 490 -1.8% YoY -3.7% QoQ | 586 39.9% YoY 19.6% QoQ | 743 34.1% YoY 26.8% QoQ |
| 2024 | 218 -57.2% YoY -70.7% QoQ | - | - | - |
The average 5 years interest of chronic cough treatment was 32.74 per week. The last year interest of chronic cough treatment compared to the last 5 years has changed by 35.8%. The interest for chronic cough treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 52.78%.
After 39 days of this quarter the interest is at 78.0. Based on that we can calculate that during remaining 52 days it will total up to 182.0. idiopathic pulmonary fibrosis treatment expected interest is significantly lower compared to previous quarter (-46.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 118 | 135 14.4% QoQ | 101 -25.2% QoQ | 131 29.7% QoQ |
| 2020 | 152 28.8% YoY 16.0% QoQ | 147 8.9% YoY -3.3% QoQ | 289 186.1% YoY 96.6% QoQ | 98 -25.2% YoY -66.1% QoQ |
| 2021 | 182 19.7% YoY 85.7% QoQ | 259 76.2% YoY 42.3% QoQ | 280 -3.1% YoY 8.1% QoQ | 126 28.6% YoY -55.0% QoQ |
| 2022 | 195 7.1% YoY 54.8% QoQ | 119 -54.1% YoY -39.0% QoQ | 71 -74.6% YoY -40.3% QoQ | 101 -19.8% YoY 42.3% QoQ |
| 2023 | 184 -5.6% YoY 82.2% QoQ | 239 100.8% YoY 29.9% QoQ | 216 204.2% YoY -9.6% QoQ | 339 235.6% YoY 56.9% QoQ |
| 2024 | 78 -57.6% YoY -77.0% QoQ | - | - | - |
The average 5 years interest of idiopathic pulmonary fibrosis treatment was 13.64 per week. The last year interest of idiopathic pulmonary fibrosis treatment compared to the last 5 years has changed by 34.38%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 84.04%.